Funding for this research was provided by:
State Key Laboratory of Respiratory Disease- The Independent project (SKLRD-QN-201720)
State Key Laboratory of Respiratory Disease- The open project (SKLRD-OP-2018011)
Guangdong High Level University Clinical Cultivation Project (2017-21020)
Wu Jieping Medical Foundation’s special funding fund for clinical research (No.320.6750.18125)
Received: 9 April 2020
Accepted: 27 May 2020
First Online: 6 June 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board at the the First Affiliated Hospital of Guangzhou Medical University. The patient provided informed consent and gave permission to this study.
: Not applicable.
: S.C. and J.X. are employees of Burning Rock Biotech. The other authors declare no potential conflicts of interest.